Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system.

Oncoimmunology·2020
Same author

Phase Behavior and Thermo-Mechanical Properties of IF-WS<sub>2</sub> Reinforced PP-PET Blend-Based Nanocomposites.

Polymers·2020
Same author

[Clinical features of children with influenza and plastic bronchitis: an analysis of 63 cases].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2020
Same author

Typical and Atypical Radiographic Features of Symptomatic Osteoblastoma in the Spine.

World neurosurgery·2020
Same author

Recoverable peroxidase-like Fe<sub>3</sub>O<sub>4</sub>@MoS<sub>2</sub>-Ag nanozyme with enhanced antibacterial ability.

Chemical engineering journal (Lausanne, Switzerland : 1996)·2020
Same author

Phytochemical Analysis, Antioxidant, Antibacterial, Cytotoxic, and Enzyme Inhibitory Activities of <i>Hedychium flavum</i> Rhizome.

Frontiers in pharmacology·2020

Related Experiment Video

Updated: Jun 21, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

IDO inhibits T-cell function through suppressing Vav1 expression and activation.

Runmei Li1, Feng Wei, Jinpu Yu

  • 1Department of Immunology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Cancer Biology & Therapy
|July 15, 2009
PubMed
Summary

Indoleamine 2,3-dioxygenase (IDO) suppresses T-cell function by inhibiting Vav1 signaling, leading to immune escape. IDO inhibitors may offer new cancer treatments by restoring T-cell responses.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Related Experiment Videos

Last Updated: Jun 21, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Indoleamine 2,3-dioxygenase (IDO) is a key enzyme in tryptophan metabolism.
  • IDO plays a critical role in immune evasion by suppressing T-cell activity.
  • The Vav1 signaling pathway is essential for maintaining T-cell homeostasis.

Purpose of the Study:

  • To investigate the hypothesis that IDO-induced T-cell immunosuppression is mediated by the inhibition of Vav1 signaling.
  • To elucidate the molecular mechanisms underlying IDO's impact on T-cell function.

Main Methods:

  • Co-culture of T cells with Chinese hamster ovary (CHO) cells expressing human IDO.
  • Assessment of T-cell proliferation, apoptosis, and interleukin-2 (IL-2) expression.
  • Analysis of Vav1 mRNA and protein expression and phosphorylation following T-cell receptor (TCR) activation.
  • Inhibition of IDO activity using 1-methyl-L-tryptophan (1-MT).

Main Results:

  • IDO expression by CHO cells significantly inhibited T-cell proliferation and IL-2 production.
  • IDO increased T-cell apoptosis and suppressed Vav1 mRNA and protein levels.
  • IDO inhibited TCR-induced Vav1 phosphorylation, indicating impaired Vav1 activation.
  • The effects of IDO on T cells were reversed by the IDO inhibitor 1-MT.

Conclusions:

  • IDO suppresses T-cell immune responses primarily through the downregulation of Vav1 protein expression and activation.
  • These findings reveal a novel mechanism of IDO-mediated immune escape.
  • Targeting IDO with inhibitors may represent a promising therapeutic strategy for enhancing anti-cancer immunity.